CoChat

MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

In search of antiinflammatory drugs with a new mechanism of action, U0126 was found to functionally antagonize AP-1 transcriptional activity via noncompetitive inhibition of the dual specificity kinase MEK with an IC50 of 0.07 microM for MEK 1 and 0.06 microM for MEK 2. U0126 can undergo isomerization and cyclization reactions to form a variety of products, both chemically and in vivo, all of which exhibit less affinity for MEK and lower inhibition of AP-1 activity than parent, U0126.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0960-894x(98)00522-8

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 11 references

Research works printed but not linked: 1

  1. Cano, 1995, TIBS, 117

Cited by

See all 404

Metadata

Authors
Duncia, J. V., Santella, J. B., Higley, C. A., Pitts, W. J., Wityak, J., Frietze, W. E., Rankin, F. W., Sun, J.-H., Earl, R. A., Tabaka, A. C., Teleha, C. A., Blom, K. F., Favata, M. F., Manos, E. J., Daulerio, A. J., Stradley, D. A., Horiuchi, K., Copeland, R. A., Scherle, P. A., Trzaskos, J. M., Magolda, R. L., Trainor, G. L., Wexler, R. R., Hobbs, F. W., & Olson, R. E.
Affiliations
DuPont (United States) (US)
Venue
Bioorganic & Medicinal Chemistry Letters
Publisher
Elsevier BV
Published
1998-10
Volume
8
Issue
20
Pages
2839-2844
ISSN
0960-894X (ISSN-L)
OpenAlex
W2094114923
Cited by
401
References
11
Citations by year
2026: 4 · 2024: 6 · 2023: 9 · 2022: 7 · 2021: 20 · 2020: 7 · 2019: 23 · 2018: 13 · 2017: 16 · 2016: 26 · 2015: 18 · 2014: 18 · 2013: 14 · 2012: 22
FWCI
2.20
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Bioorganic & Medicinal Chemistry Letters (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
U0126, MEK inhibitors, MEK1, MEK2, dual-specificity kinase, AP-1 transcriptional activity, non-competitive inhibition, isomerization, cyclization products, anti-inflammatory agents
MeSH terms
Animals, Anti-Inflammatory Agents, Biotransformation, Butadienes, Cyclization, Enzyme Inhibitors, Nitriles, NF-kappa B, Protein Serine-Threonine Kinases, Transcription Factor AP-1, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products. https://app.cochat.ai/papers/10.1016/s0960-894x(98)00522-8
The paper
Duncia, J. V., Santella, J. B., Higley, C. A., Pitts, W. J., Wityak, J., Frietze, W. E., Rankin, F. W., Sun, J.-H., Earl, R. A., Tabaka, A. C., Teleha, C. A., Blom, K. F., Favata, M. F., Manos, E. J., Daulerio, A. J., Stradley, D. A., Horiuchi, K., Copeland, R. A., Scherle, P. A., . . . Olson, R. E. (1998). MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/s0960-894x(98)00522-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.